Lupin, India

EXCEL - Experiential Cases for Empagliflozin & Linagliptin

Health EN ↓ 207 episodes

Experiential Cases for Empagliflozin & Linagliptin: Listen to Endocrinologist and Diabetologist discuss real life cases of this single pill combination in Indian T2DM patient. This talk aims to provide clinicians an expert perspective with more evidence on the benefits of Empagliflozin and Linagliptin in the management of T2DM patients.

Author

Lupin, India

Category

Health

Podcast website

podcasters.spotify.com

Latest episode

Jul 12, 2023

Where to listen?

Podcasts in the app Replaio Radio Coming soon

Podcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts

Get it on Google Play Install for free Android almost 10M downloads · 4.8 rating iOS soon

Episodes

Newly diagnosed T2D with high baseline HbA1c level | Dr. Aasim Maldar 02.06.2022

A patient with newly detected T2D, came in the clinic with high baseline HbA1c level. Listen to expert the importance of optimum glycemic control early in the disease course for better patient outcome.

HbA1c = High Baseline A1c in a middle-aged patient with short duration diabetes | Dr. Durga Prasad Rai 02.06.2022

A middle-aged patient with short duration of T2DM and multiple CV risk factors presents with uncontrolled hyperglycemia. What are the primary factors you would like to consider providing the comprehensive care to this patient? Listen to the expert. 

Newly diagnosed T2D with high baseline HbA1c level | Dr. B Ravi Kumar 02.06.2022

A patient with newly detected T2D, came in the clinic with high baseline HbA1c level. Listen to expert the importance of optimum glycemic control early in the disease course for better patient outcome.

Newly diagnosed T2D with high baseline HbA1c level | Dr. Sebabrata Jana 26.05.2022

A patient with newly detected T2D, came in the clinic with high baseline HbA1c level. Listen to expert the importance of optimum glycemic control early in the disease course for better patient outcome.

Newly diagnosed T2D with high baseline HbA1c level | Dr. Dilip Gude 26.05.2022

A patient with newly detected T2D, came in the clinic with high baseline HbA1c level. Listen to expert the importance of optimum glycemic control early in the disease course for better patient outcome.

Established Cardio-vascular disease and it’s complication in Diabetes | Dr. Partha Roy 26.05.2022

A T2DM patient with prior history of acute vascular event is recently diagnosed with type 2 diabetes mellitus. Listen to the expert to discuss the important aspects to assess and manage such patients.

HbA1c = High Baseline A1c in a middle-aged patient with short duration diabetes | Dr. Dibakar Biswas 24.05.2022

A middle-aged patient with short duration of T2DM and multiple CV risk factors presents with uncontrolled hyperglycemia. What are the primary factors you would like to consider providing the comprehensive care to this patient? Listen to the expert.

Early Initiation Benefits of Combination Therapy in Glycemic Control | Dr. S Uthra 21.05.2022

Listen to the expert on  Early Initiation  Benefits of Combination Therapy in Glycemic Control

Poorly controlled diabetes woman with genital tract infection | Dr. Vivek Arya 21.05.2022

Poorly controlled diabetes patient with multiple CV risk factors on multiple medication came to visit clinician with genitourinary tract infection. Listen to expert the importance of individualizing the anti-diabetes therapy to achieve optimum glycemic control for better patient outcome.

Rationality Of Combination Of SGLT2i And DPP-4i Combination | Dr. Manaswi Gupta 20.05.2022

Listen to the Expert on Rationality Of Combination Of SGLT2i And DPP-4i Combination.

Promising CKD Perspective Of SGLT2i And DPP4i| Dr. Manaswi Gupta 20.05.2022

Listen to the Expert on Promising CKD Perspective Of SGLT2i And DPP4i.

Emerging Benefits From Cardiovascular Renal Metabolic Aspects Of Empagliflozin And Linagliptin | Dr. Manaswi Gupta 20.05.2022

Listen to the Expert on Emerging Benefits From Cardiovascular Renal Metabolic Aspects Of Empagliflozin And Linagliptin.

Early initiation with Empagliflozin and Linagliptin combination for optimal glycemic control in T2DM | Dr. Manaswi Gupta 20.05.2022

Listen to the expert on  Early initiation with Empagliflozin and Linagliptin combination for optimal glycemic control in T2DM.

Poorly controlled diabetes with hypoglycemia risk | Dr. Ramnarayan Mundada 20.05.2022

A middle-aged person with type 2 diabetes visited the clinic with inadequate control of glycemic profile along with episodes of hypoglycemia in the recent past. Listen to the expert to achieve the optimum management of type 2 diabetes with improving tolerability profile.

A 57-Year-Old Man with Type 2 Diabetes, Hypertension, and Microalbuminuria | Dr. Akash Sampat 07.05.2022

Type 2 Diabetes patient with Hypertension and Microalbuminuria is showing clinical features of early changes of renal impairment. Listen to expert to manage inadequately controlled diabetes patients with novel emerging therapies.

Newly diagnosed T2D with high baseline HbA1c level | Dr. Ashok Gupta 06.05.2022

A patient with newly detected T2D, came in the clinic with high baseline HbA1c level. Listen to expert the importance of optimum glycemic control early in the disease course for better patient outcome.

Poorly controlled diabetes woman with genital tract infection | Dr. Deepak Verma 30.04.2022

Poorly controlled diabetes patient with multiple CV risk factors on multiple medication came to visit clinician with genitourinary tract infection. Listen to expert the importance of individualizing the anti-diabetes therapy to achieve optimum glycemic control for better patient outcome.

Glycemic variability & Time in range target achievement with OAD's | Dr. H Rajesh Krishnan 30.04.2022

Listen to the expert on  Glycemic variability & Time in range target achievement with OAD's.

Early initiation with Empagliflozin and Linagliptin combination for optimal glycemic control in T2D | Dr. Pramod Joshi 29.04.2022

Listen to the expert on  Early initiation with Empagliflozin and Linagliptin combination for optimal glycemic control in T2D

HbA1c = High Baseline A1c in a middle-aged patient with short duration diabetes | Dr. R. K. Marya 29.04.2022

A middle-aged patient with short duration of T2DM and multiple CV risk factors presents with uncontrolled hyperglycemia. What are the primary factors you would like to consider providing comprehensive care to this patient? Listen to the expert.

HbA1c = High Baseline A1c in a middle-aged patient with short duration diabetes | Dr. Amitesh Kumar Chatterjee 25.04.2022

A middle-aged patient with short duration of T2DM and multiple CV risk factors presents with uncontrolled hyperglycemia. What are the primary factors you would like to consider providing the comprehensive care to this patient? Listen to the expert.

Diabetic with established Cardio-vascular disease| Dr. Himanshu Bhatheja 23.04.2022

A T2DM patient with prior history of acute vascular event is recently diagnosed with type 2 diabetes mellitus. Listen to the expert to discuss the important aspects to assess and manage such patients.

Diabetic with established Cardio-vascular disease | Dr. Vikas Jain 23.04.2022

A T2DM patient with prior history of acute vascular event is recently diagnosed with type 2 diabetes mellitus. Listen to the expert to discuss the important aspects to assess and manage such patients.

Diabetic with established Cardio-vascular disease | Dr. Nilakshi Deka 23.04.2022

A T2DM patient with prior history of acute vascular event is recently diagnosed with type 2 diabetes mellitus. Listen to the expert to discuss the important aspects to assess and manage such patients.

Rationality Of Combination Of SGLT2i And DPP-4i Combination | Dr. Syed Mudasir Qadri 18.04.2022

Listen to the Expert on Rationality Of Combination Of SGLT2i And DPP-4i Combination.

Listen to the EXCEL - Experiential Cases for Empagliflozin & Linagliptin podcast in Replaio

Radio and podcasts in one app - free, with no sign-up. Install today and do not miss the launch

Get it on Google Play

Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.